WILMINGTON, Del. and BOSTON, Oct. 14, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (PRLD) (“Prelude”) (Nasdaq: PRLD), a clinical-stage precision oncology company, announces multiple ...
CHICAGO--(BUSINESS WIRE)--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, will present updates on three ...
‒ Poster for GP2 Phase IIb clinical trial final efficacy analysis was presented during the 2020 San Antonio Breast Cancer Symposium (SABCS) today ‒ Phase IIb clinical trial was a prospective, ...
Positive pre-clinical results, including an advanced high yielding manufacturing process, support the anticipated submission of an IND in 2024 to begin clinical development with Phase 1 single and ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting myeloid checkpoints, ...
Labroots is excited to announce the 17th Annual Event in the Clinical Diagnostics & Research Virtual Event Series taking place on November 11th, 2026! This event will again bring together clinicians, ...
Thirteen years ago, Labroots launched a new learning platform for a global scientific audience. This year, the 13th Annual Event in the Clinical Diagnostics & Research Virtual Event Series will again ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results